Approval · Notice of Compliance 1766 · 1999
SUSTIVA: Notice of Compliance 1766
Issued March 19, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1766
- Date
- March 19, 1999
- Company
- Dupont Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antiretroviral agent